Larimar Therapeutics, Inc. Quarterly Debt-to-equity in % from Q1 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Larimar Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q1 2015 to Q2 2024.
  • Larimar Therapeutics, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 11.1 %, a 10.8% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 11.1 -1.34 -10.8% Jun 30, 2024
Q1 2024 10.8 -3.53 -24.6% Mar 31, 2024
Q4 2023 13.1 -3.75 -22.2% Dec 31, 2023
Q3 2023 12.5 -6.64 -34.7% Sep 30, 2023
Q2 2023 12.5 -11 -46.8% Jun 30, 2023
Q1 2023 14.3 -7.74 -35.1% Mar 31, 2023
Q4 2022 16.9 -3.57 -17.5% Dec 31, 2022
Q3 2022 19.1 +0.14 +0.74% Sep 30, 2022
Q2 2022 23.4 +7.48 +47% Jun 30, 2022
Q1 2022 22.1 +8.14 +58.4% Mar 31, 2022
Q4 2021 20.4 +0.18 +0.89% Dec 31, 2021
Q3 2021 19 -5.5 -22.5% Sep 30, 2021
Q2 2021 15.9 -48.5 -75.3% Jun 30, 2021
Q1 2021 13.9 -2.33K -99.4% Mar 31, 2021
Q4 2020 20.3 -3.3K -99.4% Dec 31, 2020
Q3 2020 24.5 -1.82K -98.7% Sep 30, 2020
Q2 2020 64.5 -42.4 -39.7% Jun 30, 2020
Q1 2020 2.34K +2.27K +3241% Mar 31, 2020
Q4 2019 3.32K +3.27K +6533% Dec 31, 2019
Q3 2019 1.84K +1.8K +4874% Sep 30, 2019
Q2 2019 107 +75.3 +239% Jun 30, 2019
Q1 2019 70 +48.6 +227% Mar 31, 2019
Q4 2018 50 +36.2 +262% Dec 31, 2018
Q3 2018 37 +28.8 +349% Sep 30, 2018
Q2 2018 31.5 +22.8 +262% Jun 30, 2018
Q1 2018 21.4 +12.8 +148% Mar 31, 2018
Q4 2017 13.8 +4.57 +49.5% Dec 31, 2017
Q3 2017 8.25 -1.94 -19% Sep 30, 2017
Q2 2017 8.71 -1.35 -13.4% Jun 30, 2017
Q1 2017 8.64 -1.06 -10.9% Mar 31, 2017
Q4 2016 9.23 +0.43 +4.89% Dec 31, 2016
Q3 2016 10.2 +1.56 +18.1% Sep 30, 2016
Q2 2016 10.1 +0.27 +2.76% Jun 30, 2016
Q1 2016 9.7 -0.63 -6.1% Mar 31, 2016
Q4 2015 8.8 Dec 31, 2015
Q3 2015 8.63 Sep 30, 2015
Q2 2015 9.79 Jun 30, 2015
Q1 2015 10.3 Mar 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.